Definitive Contract 36C25225C0001

Award Date 10/2/24
Potential Completion Date 9/30/25
Potential Value $646K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company, for the purchase of blood bags. The potential value of the contract is $243,429.56. The contract was set aside for small businesses. The original solicitation was for the procurement of Glycerolyte 57% Glass Bottles, Military QUAD BPUm PL 1240, and Sample Access Devices for use with Filters,...
The Department of Veterans Affairs awarded a $391,423.95 firm fixed price purchase order to Fenwal, Inc. to supply specialized blood bags and blood glucose solution for the military's frozen blood program. The contract was awarded on a sole source basis after market research found Fenwal to be the only provider of the required Glycerolyte 57% glass bottles containing 100ml each and Military Quad blood bags containing 450ml each. These products have been developed specifically for the...
This is a $177,697.86 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a foreign-owned for-profit manufacturer of medical products. The contract is for the delivery of BLOOD BAGS and is set aside for small businesses. Fenwal, a subsidiary of Fresenius Kabi, is a global blood technology company that has received numerous federal contracts to provide products and services related to blood collection,...
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide blood bags for the military. The contract has a potential value of $100,519.90 and a completion date of August 31, 2022. Fenwal is a global blood technology company that has received numerous federal contract awards as a prime contractor to provide blood collection, separation, storage, and transfusion...
This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Fenwal, Inc., a Fresenius Kabi company that specializes in blood collection, separation, storage, and transfusion products and services. The contract, valued at $181,396.80, is for the delivery of Glycerolyte 57% glass bottles and Military Quad BPum PL 1240 450 CPDA1 blood bags. These products support the military's frozen blood program and are used by various federal agencies,...
This firm-fixed-price purchase order contract was awarded by the Defense Health Agency to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $846,759.26 contract is for the delivery of blood collection bags and has a completion date of November 30, 2025. Fenwal, Inc. is a foreign-owned, for-profit manufacturer specializing in blood collection, separation, storage, and transfusion products and services. The company has a strong track record of providing critical...
This federal contract award to Fenwal, Inc., a subsidiary of Fresenius Kabi, was made by the U.S. Army Medical Command (MEDCOM) for the purchase of CPD/ADSOL DBL WB RZ-2000 blood bags and related equipment. The $143,319.60 firm-fixed-price contract has an ultimate completion date of September 30, 2016 and does not have a set-aside designation. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, primarily supporting transfusion medicine...
This federal contract award is to Fenwal, Inc., a global blood technology company, for the provision of a variety of blood collection, processing, and transfusion-related products and services. The contract, valued at $22,800.00, was awarded by the Office of the Chief Operating Officer and does not have a set-aside designation. Fenwal, a subsidiary of Fresenius Kabi, is a registered federal vendor that has supplied items such as blood bags, tubing, solutions, apheresis equipment, and...
This federal contract award, valued at $1,062.50, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. The contract is for the supply of various blood collection and processing products, including blood bags, tubing, solutions, and apheresis equipment, to support transfusion medicine and cell therapy applications for federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health....
The Defense Logistics Agency Troop Support Medical has awarded Fenwal, Inc., a Fresenius Kabi company, a $1,062.50 firm-fixed-price purchase order for blood collection products and services. Fenwal, a global blood technology company, will provide items such as blood bags, tubing, solutions, and equipment to support the U.S. military's blood program and federal biomedical research. This contract was awarded without a set-aside designation due to Fenwal's specialized capabilities as a manufacturer...

The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price contract worth $645,972.48 to Fenwal, Inc., a subsidiary of Fresenius Kabi, to provide military blood bags and accessories for the Capt. James A. Lovell Federal Healthcare Center in North Chicago, Illinois. This sole-source contract, awarded under FAR 6.302-1, includes the supply of glycerolyte solution, sodium chloride solution, blood bag containers, and other specialized blood collection and processing products. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, including the Department of Defense and National Institutes of Health, for transfusion medicine and cell therapy applications. This contract does not have a set-aside designation, reflecting Fenwal's unique capabilities in the field of blood-related products and services.

Generated 10/5/24, 9:04 AM